Basilic Fly Studio Ltd
BASILICBasilic Fly Studio Ltd is cheap for a reason. The P/E sits at the 3rd percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: annual EPS moved +19.9% against a −52.9% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (38 weeks in) while the P/E sits at the 3rd percentile of its own 3-year range. Underneath, the last four quarters read deteriorating — profit −25.0% year on year, and 4% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Basilic Fly Studio Ltd trades at ₹199, in a downtrend and 38 weeks into that stage. That is −22.5% against its own 200-day average. It sits at 9% of a 52-week range of ₹174 to ₹450. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (10 weeks and counting).
Today the stock is in a downtrend — week 38 of stage 4, confirmed. At ₹199 it trades −22.5% versus its 200-day average and sits at 9% of its 52-week range (₹174–₹450).
Against the market, two honest reads. Cumulative: over the last 2.9 years the stock moved −36% while the NIFTY 500 moved +34% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (10 weeks and counting; last ahead the week of 2026-06-12) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Basilic Fly Studio Ltd trades at 9.9× P/E, near the bottom of its own range — cheaper only 3% of the time. Its long-run median P/E is 22.1×, measured across 2.9 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 9.9× is near the bottom of its own range — cheaper only 3% of the time, against a long-run median of 22.1× measured over 2.9 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +19.9% against a −52.9% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the −13.8%/yr price move, ~+7.3%/yr came from earnings growth and ~−21.1 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Basilic Fly Studio Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +34.2% | +72.9% | — | — |
| Profit | +10.9% | +22.1% | — | — |
| EPS | +19.9% | +5.8% | — | — |
| Share price | −52.9% | −13.8% | — | — |
4-Factor Sector Score
51.9/100 — rank 10 of 25 in Entertainment & Media · 70% evidence confidence
Basilic Fly Studio Ltd scores 51.9 out of 100 against the 25 companies it is compared with in Entertainment & Media, ranking 10. Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
The four contributions add to the total exactly: 13.6 + 20.5 + 14.4 + 3.4 = 51.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Basilic Fly Studio Ltd reported ₹113 Cr of revenue in the Mar 26 quarter, −15.7% year on year. Over 4 years it has compounded at 101.0% a year. The last full year, FY26, came in at ₹408 Cr. The last four reported quarters add to ₹408 Cr.
FY26 revenue came in at ₹408 Cr (+34.2% on the year), capping 4 years at 101.0% compound. The latest quarter (Mar 26) printed ₹113 Cr, −15.7% year on year.
Pace check: the last four quarters averaged +22.3% growth against the decade's 101.0% — the current year is running slower than its own long-run rate.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Basilic Fly Studio Ltd's operating margin is 21.0% in the Mar 26 quarter, −3.0 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 6.0% to 49.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 21.0%, −3.0 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 6.0%–49.0%.
🚨 Why the margin moved: operating margin went −3.3 pp year on year while gross margin went +0.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Basilic Fly Studio Ltd earned ₹15.0 Cr of net profit in the Mar 26 quarter, −25.0% year on year. Full-year FY26 profit was ₹51.0 Cr. The 4-year compound rate is 167.2%. That is 13.3% of the quarter's revenue. The same quarter a year earlier earned ₹20.0 Cr.
Mar 26 profit was ₹15.0 Cr, −25.0% year on year. On the full year, FY26 printed ₹51.0 Cr (+10.9%), and the 4-year compound rate is 167.2%.
🚨 Why profit moved: revenue contributed −15.7% and the margin −3.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +27.8% vs revenue +22.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 4% of Basilic Fly Studio Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹23.0 Cr of operating cash against ₹51.0 Cr of profit. After ₹119 Cr of capital spending, ₹−96.0 Cr was left as free cash.
FY26: operating cash of ₹23.0 Cr against reported profit of ₹51.0 Cr, leaving free cash of ₹−96.0 Cr after ₹119 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 4% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 4%: the cash cycle stretched 86 days between FY22 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 86 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Basilic Fly Studio Ltd's cash conversion cycle runs 124 days in FY26, up from 38 days in FY22. Capital spending ran ₹219 Cr over the last 3 years. At FY26 sales of ₹408 Cr each day of that cycle holds about ₹1.1 Cr, so roughly ₹139 Cr sits inside the business at any moment.
FY26: debtors at 124 days (an asset-light business — no inventory to speak of) — for a full cycle of 124 days, looser than FY22's 38.
In money terms: at FY26 sales of ₹408 Cr, each day of the cycle holds about ₹1.1 Cr — so the 124-day loop keeps roughly ₹139 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹219 Cr over the last 3 fiscal years against ₹23.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Basilic Fly Studio Ltd earns a ROCE of 22% in FY26. Return on invested capital clears the cost of that capital by +4.2 percentage points, so growth here adds value rather than only size. The wiring behind it is 12.5% net margin on 0.76× asset turns.
FY26 ROCE is 22%.
Why the return is what it is — the wiring (FY26): 12.5% net margin × 0.76× asset turns × 1.61× balance-sheet leverage ≈ 15.3% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 16.2% − 12.0% = a +4.2 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Basilic Fly Studio Ltd carries ₹106 Cr of borrowings against ₹334 Cr of equity in FY26, a debt-to-equity of 0.32. Operating profit covers the interest bill 9×. Over 4 years borrowings went from ₹4.0 Cr to ₹106 Cr. Capital spending ran ₹219 Cr across the last 3 of those years.
FY26: borrowings of ₹106 Cr against equity of ₹334 Cr — a debt-to-equity of 0.32. Operating profit covers the interest bill 9×. Over 4 years borrowings went from ₹4.0 Cr to ₹106 Cr while capital spending ran ₹219 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 4.6 points of Basilic Fly Studio Ltd over 8 quarters, the biggest move on the register. That takes promoters to 55.3% of the company. Foreign institutions moved +2.2 points over the same window, to 3.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −4.6 points over 8 quarters to 55.3%; Foreign institutions: +2.2 points over 8 quarters to 3.5%; Domestic institutions: +1.4 points over 8 quarters to 1.4%.
🚨 Why the register moved: promoters drove it (−4.6 points), absorbed on the other side by foreign institutions (+2.2 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Basilic Fly Studio Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Nazara Technologies LtdNAZARA | 77.5/100Favorable setup78% evidence | BREAKING OUT | 26.6/35 Revenue 12.6% · PAT 41.4% · OPM change 5 pp 83% evidence | 18.1/25 ROCE 27.2% · OPM 11% 76% evidence | 13.8/20 P/E 13× · PEG — 50% evidence | 19.0/20 RS sector 26% · RS bench 21.6% · 1Y -2.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 26.6 + 18.1 + 13.8 + 19 = 77.5 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Nila Spaces LtdNILASPACES | 70.2/100Favorable setup77% evidence | 27.6/35 Revenue 36.2% · PAT 95.9% · OPM change 9.5 pp 83% evidence | 19.6/25 ROCE 31.3% · OPM 35% 95% evidence | 11.7/20 P/E 17.6× · PEG — 50% evidence | 11.3/20 RS sector 4.6% · RS bench -14.5% · 1Y -8.7%0 of 7 weeks ahead to 2026-07-05 70% evidence | |
| Exact sum: 27.6 + 19.6 + 11.7 + 11.3 = 70.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3PVR Inox LtdPVRINOX | 66.3/100Favorable setup91% evidence | BREAKING OUT | 23.3/35 Revenue 13.7% · PAT 100% · OPM change 5 pp 74% evidence | 9.7/25 ROCE 7% · OPM 33% 100% evidence | 16.8/20 P/E 35× · PEG 0.65 100% evidence | 16.5/20 RS sector 10.8% · RS bench 6.9% · 1Y 13%1 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 9.7 + 16.8 + 16.5 = 66.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Prime Focus LtdPFOCUS | 63.2/100Mixed-positive evidence71% evidence | ASLEEP | 24.7/35 Revenue 29.9% · PAT 100% · OPM change 11 pp 65% evidence | 16.1/25 ROCE 11.5% · OPM 35% 100% evidence | 9.1/20 P/E 94.9× · PEG — 15% evidence | 13.3/20 RS sector 25.3% · RS bench 22.3% · 1Y 94.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.7 + 16.1 + 9.1 + 13.3 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Hindustan Media Ventures LtdHMVL | 63.1/100Mixed-positive evidence68% evidence | TURNING | 21.9/35 Revenue 9.3% · PAT -38.5% · OPM change 17 pp 83% evidence | 15.2/25 ROCE 11.5% · OPM 30% 95% evidence | 13.5/20 P/E 4.5× · PEG — 50% evidence | 12.5/20 RS sector — · RS bench 23.8% · 1Y —3 of 3 weeks ahead 25% evidence |
| Exact sum: 21.9 + 15.2 + 13.5 + 12.5 = 63.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Sun TV Network LtdSUNTV | 54.5/100Mixed-positive evidence96% evidence | BASING | 16.2/35 Revenue 7.8% · PAT -15.5% · OPM change 0 pp 88% evidence | 19.6/25 ROCE 16.5% · OPM 44% 100% evidence | 12.4/20 P/E 13.4× · PEG 1.37 100% evidence | 6.3/20 RS sector -7.1% · RS bench -10.1% · 1Y -11.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 19.6 + 12.4 + 6.3 = 54.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7City Pulse Multiventures Ltd542727 | 54.3/100Mixed-positive evidence65% evidence | ASLEEP | 22.5/35 Revenue 100% · PAT 100% · OPM change -166.4 pp 83% evidence | 11.3/25 ROCE 2.6% · OPM 78.6% 76% evidence | 8.5/20 P/E 347× · PEG — 15% evidence | 12.0/20 RS sector 42.1% · RS bench -83.6% · 1Y -80.9%0 of 10 weeks ahead 70% evidence |
| Exact sum: 22.5 + 11.3 + 8.5 + 12 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Amagi Media Labs LtdAMAGI | 52.8/100Thin evidence · provisional51% evidence | BREAKING OUT | 25.4/35 Revenue 31.4% · PAT — · OPM change 10.3 pp 65% evidence | 8.4/25 ROCE 8% · OPM 6% 100% evidence | 9.0/20 P/E 196× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —9 of 12 weeks ahead 0% evidence |
| Exact sum: 25.4 + 8.4 + 9 + 10 = 52.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Media Matrix Worldwide LtdMMWL | 52.1/100Mixed-positive evidence68% evidence | BREAKING OUT | 12.6/35 Revenue -33.4% · PAT 80.2% · OPM change -0.2 pp 62% evidence | 12.5/25 ROCE 9.8% · OPM 1.8% 95% evidence | 8.7/20 P/E 266× · PEG — 15% evidence | 18.3/20 RS sector 22.2% · RS bench 17.4% · 1Y -14.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 12.5 + 8.7 + 18.3 = 52.1 · Decision use: Price leads the evidence: RS versus the benchmark is 17.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10Basilic Fly Studio Ltdthis pageBASILIC | 51.9/100Mixed-positive evidence70% evidence | ASLEEP | 13.6/35 Revenue — · PAT — · OPM change -3 pp 45% evidence | 20.5/25 ROCE 22.3% · OPM 21% 95% evidence | 14.4/20 P/E 9.9× · PEG — 50% evidence | 3.4/20 RS sector -29.4% · RS bench -32.5% · 1Y -52.3%3 of 12 weeks ahead 100% evidence |
| Exact sum: 13.6 + 20.5 + 14.4 + 3.4 = 51.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 11H T Media LtdHTMEDIA | 49.2/100Mixed-negative evidence61% evidence | TURNING | 17.0/35 Revenue 3.6% · PAT -80% · OPM change 11.5 pp 83% evidence | 9.8/25 ROCE 7.4% · OPM 16.5% 95% evidence | 11.5/20 P/E 4.3× · PEG — 15% evidence | 10.9/20 RS sector — · RS bench 2.4% · 1Y —3 of 3 weeks ahead 25% evidence |
| Exact sum: 17 + 9.8 + 11.5 + 10.9 = 49.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Zee Media Corporation LtdZEEMEDIA | 43.5/100Mixed-negative evidence62% evidence | ASLEEP | 20.9/35 Revenue 22% · PAT 100% · OPM change -1 pp 62% evidence | 8.5/25 ROCE 5.3% · OPM -6% 95% evidence | 9.6/20 P/E 73.8× · PEG — 15% evidence | 4.5/20 RS sector -23.3% · RS bench -20.3% · 1Y -44.9%2 of 10 weeks ahead 70% evidence |
| Exact sum: 20.9 + 8.5 + 9.6 + 4.5 = 43.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Panorama Studios International Ltd539469 | 42.6/100Mixed-negative evidence65% evidence | TURNING | 9.7/35 Revenue -15.3% · PAT -74.9% · OPM change -1 pp 83% evidence | 13.4/25 ROCE 8.7% · OPM 19.9% 76% evidence | 9.4/20 P/E 82× · PEG — 15% evidence | 10.1/20 RS sector -8.8% · RS bench 6.2% · 1Y -7.7%7 of 10 weeks ahead 70% evidence |
| Exact sum: 9.7 + 13.4 + 9.4 + 10.1 = 42.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Dish TV India LtdDISHTV | 40.7/100Mixed-negative evidence65% evidence | ASLEEP | 15.1/35 Revenue -25.9% · PAT -65.6% · OPM change -57 pp 62% evidence | 12.6/25 ROCE 70% · OPM -29% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.0/20 RS sector -22.5% · RS bench -25.9% · 1Y -47.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 15.1 + 12.6 + 10 + 3 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Hathway Cable & Datacom LtdHATHWAY | 39.8/100Mixed-negative evidence87% evidence | ASLEEP | 13.5/35 Revenue 5.7% · PAT -28.3% · OPM change -4 pp 95% evidence | 7.7/25 ROCE 2.6% · OPM 13% 95% evidence | 9.4/20 P/E 25.2× · PEG — 50% evidence | 9.2/20 RS sector -8.4% · RS bench -12.2% · 1Y -29.1%4 of 12 weeks ahead 100% evidence |
| Exact sum: 13.5 + 7.7 + 9.4 + 9.2 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Den Networks LtdDEN | 39.1/100Mixed-negative evidence81% evidence | ASLEEP | 11.7/35 Revenue -2.3% · PAT -29.8% · OPM change -3.3 pp 95% evidence | 8.2/25 ROCE 5.6% · OPM 4.7% 95% evidence | 11.7/20 P/E 8.8× · PEG — 50% evidence | 7.5/20 RS sector -9.6% · RS bench -11% · 1Y -26.6%2 of 10 weeks ahead 70% evidence |
| Exact sum: 11.7 + 8.2 + 11.7 + 7.5 = 39.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Network 18 Media & Investments LtdNETWORK18 | 38.5/100Mixed-negative evidence66% evidence | ASLEEP | 18.7/35 Revenue -48.5% · PAT 97.8% · OPM change 0.5 pp 95% evidence | 5.8/25 ROCE 3% · OPM 1.4% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.0/20 RS sector -23.6% · RS bench -27.9% · 1Y -49%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.7 + 5.8 + 10 + 4 = 38.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Zee Entertainment Enterprises LtdZEEL | 36.5/100Mixed-negative evidence90% evidence | TURNING | 7.9/35 Revenue -2.4% · PAT -60.1% · OPM change -27 pp 88% evidence | 5.8/25 ROCE 2.8% · OPM -13% 100% evidence | 13.3/20 P/E 39.4× · PEG 0.28 100% evidence | 9.5/20 RS sector -15.2% · RS bench 15.1% · 1Y -7.4%8 of 10 weeks ahead 70% evidence |
| Exact sum: 7.9 + 5.8 + 13.3 + 9.5 = 36.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 19New Delhi Television LtdNDTV | 30.5/100Adverse evidence69% evidence | ASLEEP | 10.5/35 Revenue 12.1% · PAT -39.6% · OPM change -4 pp 71% evidence | 1.4/25 ROCE -72.6% · OPM -58% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.6/20 RS sector -10.9% · RS bench -14.5% · 1Y -33.8%4 of 12 weeks ahead 100% evidence |
| Exact sum: 10.5 + 1.4 + 10 + 8.6 = 30.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20GTPL Hathway LtdGTPL | 30.1/100Adverse evidence81% evidence | ASLEEP | 10.7/35 Revenue 8.3% · PAT -80% · OPM change -1.5 pp 95% evidence | 9.9/25 ROCE 3.4% · OPM 10.3% 95% evidence | 6.2/20 P/E 84.4× · PEG — 50% evidence | 3.3/20 RS sector -30.5% · RS bench -29.9% · 1Y -50.5%1 of 10 weeks ahead 70% evidence |
| Exact sum: 10.7 + 9.9 + 6.2 + 3.3 = 30.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21T.V. Today Network LtdTVTODAY | 29.6/100Adverse evidence77% evidence | ASLEEP | 10.0/35 Revenue -18.8% · PAT -80% · OPM change 0.3 pp 83% evidence | 6.8/25 ROCE 4.5% · OPM 2.1% 95% evidence | 6.7/20 P/E 26.2× · PEG — 50% evidence | 6.1/20 RS sector -17% · RS bench -12.9% · 1Y -33.2%2 of 10 weeks ahead 70% evidence |
| Exact sum: 10 + 6.8 + 6.7 + 6.1 = 29.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Entertainment Network (India) LtdENIL | 26.9/100Adverse evidence77% evidence | ASLEEP | 7.8/35 Revenue 3.9% · PAT -80% · OPM change -11.1 pp 83% evidence | 4.0/25 ROCE -0.8% · OPM 7.5% 95% evidence | 6.2/20 P/E 264× · PEG — 50% evidence | 8.9/20 RS sector -2.6% · RS bench -13.8% · 1Y -27.1%2 of 10 weeks ahead 70% evidence |
| Exact sum: 7.8 + 4 + 6.2 + 8.9 = 26.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Balaji Telefilms LtdBALAJITELE | 22.3/100Adverse evidence68% evidence | ASLEEP | 5.2/35 Revenue -53.1% · PAT -80% · OPM change -7 pp 83% evidence | 3.9/25 ROCE -9.5% · OPM -36% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.2/20 RS sector -15.5% · RS bench -18.6% · 1Y -10.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 5.2 + 3.9 + 10 + 3.2 = 22.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Bright Outdoor Media Ltd543831 | 61.8/100Thin evidence · provisional48% evidence | 20.4/35 Revenue 50.9% · PAT 100% · OPM change 1 pp 27% evidence | 16.4/25 ROCE 15.7% · OPM 23% 57% evidence | 9.3/20 P/E 43.7× · PEG — 50% evidence | 15.7/20 RS sector 23% · RS bench 17.4% · 1Y 4.4%12 of 12 weeks ahead to 2026-04-05 70% evidence | |
| Exact sum: 20.4 + 16.4 + 9.3 + 15.7 = 61.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25DAPS Advertising Ltd543651 | 51.1/100Thin evidence · provisional43% evidence | 18.0/35 Revenue — · PAT — · OPM change 0.7 pp 15% evidence | 12.9/25 ROCE 9.9% · OPM 5.4% 57% evidence | 13.8/20 P/E 8.5× · PEG — 50% evidence | 6.4/20 RS sector -20.9% · RS bench -6.2% · 1Y -19.9%0 of 10 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 18 + 12.9 + 13.8 + 6.4 = 51.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Basilic Fly Studio Ltd's share price today?
Basilic Fly Studio Ltd trades at ₹199, −52.9% over the past year. The company is valued at ₹504 Cr. The stock sits at 9% of its 52-week range of ₹174–₹450, −22.5% versus its 200-day average. On the tape, the price is in a downtrend, 38 weeks in. — as of 31 July 2026.
What were Basilic Fly Studio Ltd's latest quarterly results?
Basilic Fly Studio Ltd reported revenue of ₹113 Cr and net profit of ₹15.0 Cr for the Mar 26 quarter. Revenue fell 15.7% and profit fell 25.0% year on year. Earnings per share were ₹5.38. The operating margin was 21.0%, 3.0 pp lower than a year earlier. — as of 31 July 2026.
What is Basilic Fly Studio Ltd's revenue?
Basilic Fly Studio Ltd reported revenue of ₹113 Cr in the Mar 26 quarter, −15.7% year on year. For the full FY26 fiscal year, revenue was ₹408 Cr (+34.2%). Over the last 4 years revenue compounded at 101.0% a year. — as of 31 July 2026.
What is Basilic Fly Studio Ltd's profit?
Basilic Fly Studio Ltd earned ₹15.0 Cr of net profit in the Mar 26 quarter, −25.0% year on year. Full-year FY26 profit was ₹51.0 Cr. The operating margin ran 21.0% in the latest quarter. — as of 31 July 2026.
What is Basilic Fly Studio Ltd's market cap?
Basilic Fly Studio Ltd's market capitalisation is ₹504 Cr at a share price of ₹199. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Basilic Fly Studio Ltd's P/E ratio?
Basilic Fly Studio Ltd trades at a P/E of 9.9×, at the 3rd percentile of its own 3-year range, against a long-run median of 22.1×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Basilic Fly Studio Ltd pay a dividend?
No — Basilic Fly Studio Ltd has recorded a dividend payout of 0% of profit in each of its last 5 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is Basilic Fly Studio Ltd overvalued?
On its own history, Basilic Fly Studio Ltd looks cheap against its own history: its P/E of 9.9× has been cheaper only 3% of the time in 3 years (long-run median 22.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Basilic Fly Studio Ltd growing?
Not right now — Basilic Fly Studio Ltd's latest numbers are shrinking: latest-quarter revenue −15.7% year on year, profit −25.0%, and the margin −3.0 pp at 21.0%. The 4-year compound rates are 101.0% (revenue) and 167.2% (profit). The earnings engine currently reads: deteriorating — as of 31 July 2026.
How is Basilic Fly Studio Ltd performing?
Basilic Fly Studio Ltd is in a downtrend, 38 weeks in. Its latest quarter's revenue fell 15.7% and profit fell 25.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 10 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Basilic Fly Studio Ltd in an uptrend?
No — the price is in a downtrend (week 38 of stage 4), trading −22.5% versus its 200-day average and at 9% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Basilic Fly Studio Ltd beating the market?
Not lately — on a trailing-13-week view Basilic Fly Studio Ltd is currently behind the NIFTY 500 (10 weeks and counting; last ahead the week of 2026-06-12), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 2.9 years the stock moved −36% against the NIFTY 500's +34% — behind the index over the full window. — as of 31 July 2026.
Will Basilic Fly Studio Ltd's share price go up?
This page publishes no price forecast for Basilic Fly Studio Ltd. What it measures instead: the share price is ₹199, the price is in a downtrend 38 weeks in. Its P/E of 9.9× sits at the 3rd percentile of its own 3-year range. — as of 31 July 2026.
Who owns Basilic Fly Studio Ltd?
Promoters hold 55.3% of Basilic Fly Studio Ltd, foreign institutions 3.5%, domestic institutions 1.4% and the public 39.8% (latest quarter). The biggest move on the register over the last two years: Promoters cut 4.6 points over 8 quarters. — as of 31 July 2026.
Does Basilic Fly Studio Ltd have too much debt?
It is moderate — Basilic Fly Studio Ltd's debt-to-equity is 0.32, and operating profit covers the interest bill 9×. FY26 borrowings were ₹106 Cr against equity of ₹334 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Basilic Fly Studio Ltd's capex?
Basilic Fly Studio Ltd spent ₹219 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹119 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Basilic Fly Studio Ltd's cash flow?
Basilic Fly Studio Ltd generated ₹23.0 Cr of operating cash flow in FY26 and ₹−96.0 Cr of free cash flow after ₹119 Cr of capital spending. Reported profit that year was ₹51.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Basilic Fly Studio Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 4% of Basilic Fly Studio Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹23.0 Cr against reported profit of ₹51.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.
Where is Basilic Fly Studio Ltd in its business cycle?
Basilic Fly Studio Ltd's FY26 operating margin was 21.0%, against a 5-year band of 6.0%–49.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 21.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Basilic Fly Studio Ltd story?
The sharpest disagreement: annual EPS moved +19.9% against a −52.9% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Basilic Fly Studio Ltd a stock worth studying right now?
This is not investment advice. The machine read: Basilic Fly Studio Ltd is cheap for a reason. The P/E sits at the 3rd percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.